The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10651 malaria professionals are enjoying the free benefits of MalariaWorld today

Plasmodium vivax

Primaquine radical cure of Plasmodium vivax: a critical review of the literature

August 22, 2012 - 07:02 -- Kabogo Ndegwa
Author(s): 
John GK, Douglas NM, von Seidlein L, Nosten F, Baird KJ, White NJ, Price RN
Reference: 
Malaria Journal 2012, 11:280 (17 August 2012)

MalariaWorldLow dose regimens retain adequate efficacy in some areas, but this is not uniform.

Product: 
Medical Condition: 

Development, validation and evaluation of a rapid PCR-nucleic acid lateral flow immuno-assay for the detection of Plasmodium and the differentiation between Plasmodium falciparum and Plasmodium vivax

August 22, 2012 - 06:57 -- Kabogo Ndegwa
Author(s): 
Mens PF, Moers AP, de Bes LM, Flint J, Sak JR, Keereecharoen L, van Overmeir C, Verweij JJ, Hallett RL, Wihokhoen B, Proux S, Schallig HD, van Amerongen A
Reference: 
Malaria Journal 2012, 11:279 (17 August 2012)

MalariaWorldPCR-NALFIA is a sensitive, specific and robust assay able to identify Plasmodium species with good accuracy.

An Analytical Method for Assessing Stage-Specific Drug Activity in Plasmodium vivax Malaria: Implications for Ex Vivo Drug Susceptibility Testing

August 15, 2012 - 07:30 -- Kabogo Ndegwa
Author(s): 
Douglas H. Kerlin, Kane Boyce, Jutta Marfurt, Julie A. Simpson, Enny Kenangalem, Qin Cheng, Ric N. Price, Michelle L. Gatton
Reference: 
PLoS Negl Trop Dis 6(8): e1772

MalariaWorldThe emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent need for an improved understanding of the mechanisms of drug resistance in these parasites, the development of robust tools for defining the spread of resistance, and the discovery of new antimalarial agents.

Medical Condition: 

Estimating the malaria transmission of Plasmodium vivax based on serodiagnosis

August 3, 2012 - 07:06 -- Kabogo Ndegwa
Author(s): 
Kim J, Kim H, Na B, Kim Y, Sohn Y, Kim H, Kim T, Lee H
Reference: 
Malaria Journal 2012, 11:257 (1 August 2012)

MalariaWorldBlood samples were collected in Gimpo city, Paju city, Yeoncheon County, Cheorwon County and Goseong County of high risk area in South Korea.

Country: 
Medical Condition: 

Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan

August 2, 2012 - 13:29 -- Patrick Sampao
Author(s): 
Mahgoub H, Gasim GI, Musa IR, Adam I
Reference: 
Parasites & Vectors 2012, 5:154 (30 July 2012)

MalariaWorldClinical pattern/manifestations of severe P. vivax were described in children admitted at New Halfa Hospital in Sudan between September 2009-December 2011.

Person: 
Country: 
Medical Condition: 

NOT Open Access | Cloning and characterization of Plasmodium vivax thioredoxin peroxidase-1

July 26, 2012 - 07:06 -- Kabogo Ndegwa
Author(s): 
Hassan Hakimi, Masahito Asada, Jose Ma. M. Angeles, Noboru Inoue & Shin-ichiro Kawazu
Reference: 
Parasitology Research, Volume 111, Number 2 (2012), 525-529

MalariaWorldReactive oxygen species produced from hemoglobin digestion and the host immune system could have adverse effects on malaria parasites.

Medical Condition: 

Not Open Access | Source of Homologous Parasites in Recurrent Plasmodium vivax Malaria

July 25, 2012 - 15:36 -- Patrick Sampao
Author(s): 
Miles B. Markus
Reference: 
J Infect Dis. (2012)

MalariaWorldIn the group of infants with Plasmodium vivax malaria that was monitored by Imwong et al , most of the first recurrences were found to be caused by parasites that were genotypically similar to those that had given rise to the initial clinical symptoms.

Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia

July 25, 2012 - 13:51 -- Kabogo Ndegwa
Author(s): 
Eshetu T, Abdo N, Bedru KH, Fekadu S, Wieser A, Pritsch M, Löscher T, Berens-Riha N
Reference: 
Malaria Journal 2012, 11:240 (23 July 2012)

MalariaWorldIn general, AL was effective and well tolerated in Jimma Zone, Ethiopia.

Country: 
Medical Condition: 

Not Open Access | Molecular markers for detection and differentiation of Plasmodium falciparum and Plasmodium vivax in human blood samples by pyrosequencing

July 18, 2012 - 15:21 -- Patrick Sampao
Author(s): 
Lulitanond V, Intapan PM, Tantrawatpan C, Sankuntaw N, Sanpool O, Janwan P, Maleewong W.
Reference: 
J Clin Microbiol. 2012 Apr;50(4):1455-7

PCR amplification coupled with pyrosequencing was used to measure molecular markers that could be used to detect and differentiate Plasmodium falciparum and Plasmodium vivax in human blood samples.

Not Open Access | Plasmodium vivax remains responsive to chloroquine with primaquine treatment regimen: a prospective cohort study from tertiary care teaching hospital in southern India

July 18, 2012 - 15:17 -- Patrick Sampao
Author(s): 
Kavitha Saravu, MD DNB, Vasudeva Acharya, MD DNB, Krishna Kumar, MD and Rishikesh Kumar, MSc MLT
Reference: 
Trop Doct July 2012 vol. 42 no. 3 163-164

We conducted this prospective study among 110 symptomatic Plasmodium vivax patients attending the Kasturba Hospital, Manipal, India, in order to evaluate their clinico-laboratory profile during July 2007–July 2009.

Country: 
Medical Condition: 
Medical Treatment: 

Pages

Subscribe to RSS - Plasmodium vivax